ClearOne, Inc. Reports Third Quarter 2022 Financial Results
ClearOne Inc. (NASDAQ: CLRO) reported Q3 2022 revenue of $6.3 million, a 10% decline year-over-year attributed to a 59% drop in video products. However, audio conferencing revenue grew by 10%. Non-GAAP operating expenses fell 30% to $3.0 million, leading to a 65% reduction in non-GAAP net loss, which stood at $0.5 million. GAAP net loss was $1.2 million, or $0.05 per share. Cash reserves decreased to $1.5 million from $4.1 million at year-end 2021. The company continues to navigate supply chain challenges due to its manufacturing transition from China to Singapore.
- 10% growth in audio conferencing solutions revenue.
- Non-GAAP operating expenses declined by 30%.
- Non-GAAP net loss decreased by 65%.
- Overall revenue declined by 10% year-over-year.
- 59% decline in video products revenue.
- Cash reserves decreased from $4.1 million to $1.5 million.
-
Non-GAAP Operating Expenses decline by
30% -
Non-GAAP Net loss declines by
65% -
Overall Q3 revenue declines
10% year-over-year despite10% growth in audio conferencing solutions
"We continue to expand our market share with our audio conferencing products as our revenue from these products continue to grow. Our audio conferencing revenue growth would have been higher if we could have procured more inventory to meet the demand for professional audio products and beamforming microphone arrays (BMAs). Our ability to build products to fill our sales backlog was hampered by the ongoing transition of our manufacturing from
"The deep cost-cutting measures that we implemented in Q2 of this year have generated a significant cash savings and helped us conserve cash as well as get closer to our goal of reaching profitability," Graham added.
Recent Highlights
-
On
July 26, 2022 ,ClearOne introduced the CONVERGENCE®InSite server network hardware that enables remote device management by facilitating bi-directional communications between its Cloud or Enterprise AV Manager and on-site ClearOne Pro Audio products. -
On
August 3, 2022 ,ClearOne announced the addition of two new US manufacturer sales representatives:Phoenix based Mountain AV Marketing, andDenver based Momentum Group. -
The U.S. District Court for the Northern District of Illinois granted ClearOne’s joint request with Shure to stay all proceedings untilJanuary 6, 2023 , to allow the parties to engage in settlement negotiations.
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
-
Revenue in 2022-Q3 was
, compared to$6.3 million in 2021-Q3 and$7.0 million in 2022-Q2. The decrease in year-over-year revenue was primarily due to a$7.4 million 59% decline in video products and a7% decline in microphones, which were partially offset by a10% increase in audio conferencing. -
GAAP gross profit in 2022-Q3 was
compared to$2.6 million in 2021-Q3 and$2.9 million in 2022-Q2. GAAP gross profit margin was$2.8 million 41.0% in 2022-Q3, compared to40.8% in 2021-Q3 and38.1% in 2022-Q2. -
Operating expenses in 2022-Q3 were
, compared to$3.7 million in 2021-Q3 and$4.9 million in 2022-Q2. Non-GAAP operating expenses in 2022-Q3 were$4.5 million , compared to$3.0 million in 2021-Q3 and$4.2 million in 2022-Q2. The year over year decrease in Non-GAAP operating expenses was mainly due to (a) reduction in employee related expenses and consultant expenses caused by a decrease in headcount, (b) decrease in commissions paid to employees and consultants, and (c) decrease in R&D project-related expenses.$3.7 million -
GAAP net loss in 2022-Q3 was
, or$1.2 million per share, compared to net loss of$0.05 , or$2.2 million per share, in 2021-Q3 and net loss of$0.11 , or$0.3 million per share, in 2022-Q2. The decrease in year-over-year quarterly net loss was mainly due to reduction in operating expenses, which was partially offset by reduction in gross margin caused by a decline in revenues. The increase in sequential quarterly net loss was mainly due to the recognition of$0.01 in gain from the forgiveness of CARES Act Paycheck Protection Program Loan in 2022-Q2, which was partially offset by a reduction in operating expenses.$1.5 million -
Non-GAAP net loss in 2022-Q3 was
, or$0.5 million per share, compared to net loss of$0.02 , or$1.6 million per share, in 2021-Q3 and net loss of$0.08 , or$1.1 million per share, in 2022-Q2. The decrease in quarterly net loss in 2022-Q3 when compared to 2021-Q3 and 2022-Q2 was mainly due to a reduction in operating expenses, which was partially offset by a reduction in gross margin due to a decline in revenues.$0.04
($ in 000, except per share) |
|
Three months ended |
|
Nine months ended |
|
|||||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
Change in %
|
|
|
2022 |
|
|
|
2021 |
|
|
Change in %
|
|
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
$ |
6,264 |
|
|
$ |
6,992 |
|
|
(10 |
) |
$ |
21,184 |
|
|
$ |
21,765 |
|
$ |
(3 |
) |
Gross profit |
|
2,570 |
|
|
|
2,851 |
|
|
(10 |
) |
|
8,193 |
|
|
|
9,278 |
|
|
(12 |
) |
Operating expenses |
|
3,700 |
|
|
|
4,860 |
|
|
24 |
|
12,825 |
|
|
|
14,297 |
|
|
10 |
|
|
Operating loss |
|
(1,130 |
) |
|
|
(2,009 |
) |
|
44 |
|
(4,632 |
) |
|
|
(5,019 |
) |
|
8 |
||
Net loss |
|
(1,248 |
) |
|
|
(2,169 |
) |
|
42 |
|
(3,472 |
) |
|
|
(5,410 |
) |
|
36 |
|
|
Diluted loss per share |
|
(0.05 |
) |
|
|
(0.11 |
) |
|
55 |
|
|
(0.15 |
) |
|
|
(0.28 |
) |
|
46 |
|
Non-GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP gross profit |
$ |
2,572 |
|
|
$ |
2,853 |
|
|
(10 |
) |
$ |
8,199 |
|
|
$ |
9,285 |
|
$ |
(12 |
) |
Non-GAAP operating expenses |
|
2,992 |
|
|
4,244 |
|
|
30 |
|
|
10,704 |
|
|
|
12,568 |
|
|
(15 |
) |
|
Non-GAAP operating loss |
|
(420 |
) |
|
|
(1,391 |
) |
|
70 |
|
(2,505 |
) |
|
|
(3,283 |
) |
|
24 |
||
Non-GAAP net loss |
|
(538 |
) |
|
|
(1,551 |
) |
|
65 |
|
(2,873 |
) |
|
|
(3,674 |
) |
|
22 |
||
Non-GAAP Adjusted EBITDA |
|
(360 |
) |
|
|
(1,295 |
) |
|
72 |
|
(2,321 |
) |
|
|
(2,983 |
) |
|
22 |
||
Non-GAAP loss per share (diluted) |
|
(0.02 |
) |
|
|
(0.08 |
) |
|
75 |
|
|
(0.12 |
) |
|
|
(0.19 |
) |
|
38 |
|
Balance Sheet Highlights
As of
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value and the possible outcomes of litigation, are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
In particular, the financial information contained herein is subject to and qualified by reference to the financial statements contained in the 10-Q, including the footnotes thereto, as well as the Company’s annual report on Form 10-K for the year ended
|
||||||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(Dollars in thousands, except par value) |
||||||||
|
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,450 |
|
|
$ |
1,071 |
|
Marketable securities |
|
|
— |
|
|
|
1,790 |
|
Receivables, net of allowance for doubtful accounts of |
|
|
4,123 |
|
|
|
4,991 |
|
Inventories, net |
|
|
9,708 |
|
|
|
10,033 |
|
Income tax receivable |
|
|
7,535 |
|
|
|
7,535 |
|
Prepaid expenses and other assets |
|
|
1,970 |
|
|
|
4,021 |
|
Total current assets |
|
|
24,786 |
|
|
|
29,441 |
|
Long-term marketable securities |
|
|
— |
|
|
|
1,220 |
|
Long-term inventories, net |
|
|
2,961 |
|
|
|
3,567 |
|
Property and equipment, net |
|
|
552 |
|
|
|
744 |
|
Operating lease - right of use assets, net |
|
|
1,088 |
|
|
|
1,537 |
|
Intangibles, net |
|
|
23,783 |
|
|
|
25,086 |
|
Other assets |
|
|
4,587 |
|
|
|
4,597 |
|
Total assets |
|
$ |
57,757 |
|
|
$ |
66,192 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
2,052 |
|
|
$ |
5,388 |
|
Accrued liabilities |
|
|
2,477 |
|
|
|
2,549 |
|
Deferred product revenue |
|
|
73 |
|
|
|
54 |
|
Short-term debt |
|
|
855 |
|
|
|
3,481 |
|
Total current liabilities |
|
|
5,457 |
|
|
|
11,472 |
|
Long-term debt, net |
|
|
1,008 |
|
|
|
1,535 |
|
Operating lease liability, net of current |
|
|
559 |
|
|
|
1,026 |
|
Other long-term liabilities |
|
|
655 |
|
|
|
655 |
|
Total liabilities |
|
|
7,679 |
|
|
|
14,688 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
24 |
|
|
|
22 |
|
Additional paid-in capital |
|
|
74,886 |
|
|
|
72,795 |
|
Accumulated other comprehensive loss |
|
|
(288 |
) |
|
|
(241 |
) |
Accumulated deficit |
|
|
(24,544 |
) |
|
|
(21,072 |
) |
Total shareholders' equity |
|
|
50,078 |
|
|
|
51,504 |
|
Total liabilities and shareholders' equity |
|
$ |
57,757 |
|
|
$ |
66,192 |
|
|
||||||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS |
||||||||||||||||
(Dollars in thousands, except per share values) |
||||||||||||||||
|
|
Three months ended |
|
|
Nine months ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Revenue |
|
$ |
6,264 |
|
|
$ |
6,992 |
|
|
$ |
21,184 |
|
|
$ |
21,765 |
|
Cost of goods sold |
|
|
3,694 |
|
|
|
4,141 |
|
|
|
12,991 |
|
|
|
12,487 |
|
Gross profit |
|
|
2,570 |
|
|
|
2,851 |
|
|
|
8,193 |
|
|
|
9,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
1,151 |
|
|
|
1,692 |
|
|
|
4,273 |
|
|
|
5,020 |
|
Research and product development |
|
|
876 |
|
|
|
1,492 |
|
|
|
3,406 |
|
|
|
4,253 |
|
General and administrative |
|
|
1,673 |
|
|
|
1,676 |
|
|
|
5,146 |
|
|
|
5,024 |
|
Total operating expenses |
|
|
3,700 |
|
|
|
4,860 |
|
|
|
12,825 |
|
|
|
14,297 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(1,130 |
) |
|
|
(2,009 |
) |
|
|
(4,632 |
) |
|
|
(5,019 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(90 |
) |
|
|
(150 |
) |
|
|
(285 |
) |
|
|
(369 |
) |
Other income, net |
|
|
(3 |
) |
|
|
7 |
|
|
1,505 |
|
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(1,223 |
) |
|
|
(2,152 |
) |
|
|
(3,412 |
) |
|
|
(5,371 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
25 |
|
|
|
17 |
|
|
|
60 |
|
|
|
39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,248 |
) |
|
$ |
(2,169 |
) |
|
$ |
(3,472 |
) |
|
|
(5,410 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
23,952,555 |
|
|
|
19,449,283 |
|
|
|
23,933,033 |
|
|
|
19,002,758 |
|
Diluted weighted average shares outstanding |
|
|
23,952,555 |
|
|
|
19,449,283 |
|
|
|
23,933,033 |
|
|
|
19,002,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per share |
|
$ |
(0.05 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.28 |
) |
Diluted loss per share |
|
$ |
(0.05 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.28 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
(1,248 |
) |
|
|
(2,169 |
) |
|
|
(3,472 |
) |
|
|
(5,410 |
) |
Unrealized gain (loss) on available-for-sale securities, net of tax |
|
|
— |
|
|
(8 |
) |
|
|
(2 |
) |
|
|
(13 |
) |
|
Change in foreign currency translation adjustment |
|
|
(22 |
) |
|
|
(4 |
) |
|
|
(45 |
) |
|
|
(26 |
) |
Comprehensive loss |
|
|
(1,270 |
) |
|
|
(2,181 |
) |
|
|
(3,519 |
) |
|
|
(5,449 |
) |
|
||||||||||||||||
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES |
||||||||||||||||
(Dollars in thousands, except per share values) |
||||||||||||||||
|
|
Three months ended |
|
|
Nine months ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
GAAP gross profit |
|
$ |
2,570 |
|
|
$ |
2,851 |
|
|
$ |
8,193 |
|
|
$ |
9,278 |
|
Stock-based compensation |
|
|
2 |
|
|
|
2 |
|
|
|
6 |
|
|
|
7 |
|
Non-GAAP gross profit |
|
$ |
2,572 |
|
|
$ |
2,853 |
|
|
$ |
8,199 |
|
|
$ |
9,285 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating loss |
|
$ |
(1,130 |
) |
|
$ |
(2,009 |
) |
|
$ |
(4,632 |
) |
|
|
(5,019 |
) |
Stock-based compensation |
|
|
24 |
|
|
|
36 |
|
|
|
89 |
|
|
|
100 |
|
Amortization of intangibles |
|
|
686 |
|
|
|
582 |
|
|
|
2,038 |
|
|
|
1,636 |
|
Non-GAAP operating loss |
|
$ |
(420 |
) |
|
$ |
(1,391 |
) |
|
$ |
(2,505 |
) |
|
$ |
(3,283 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(1,248 |
) |
|
$ |
(2,169 |
) |
|
$ |
(3,472 |
) |
|
|
(5,410 |
) |
Stock-based compensation |
|
|
24 |
|
|
|
36 |
|
|
|
89 |
|
|
|
100 |
|
Amortization of intangibles |
|
|
686 |
|
|
|
582 |
|
|
|
2,038 |
|
|
|
1,636 |
|
CARES Act PPP loan forgiveness |
|
|
— |
|
|
— |
|
|
|
(1,528 |
) |
|
|
— |
|
|
Non-GAAP net loss |
|
$ |
(538 |
) |
|
$ |
(1,551 |
) |
|
$ |
(2,873 |
) |
|
$ |
(3,674 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(1,248 |
) |
|
$ |
(2,169 |
) |
|
$ |
(3,472 |
) |
|
$ |
(5,410 |
) |
Number of shares used in computing GAAP loss per share (diluted) |
|
|
23,952,555 |
|
|
|
19,449,283 |
|
|
|
23,933,033 |
|
|
|
19,002,758 |
|
GAAP loss per share (diluted) |
|
$ |
(0.05 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.28 |
) |
Non-GAAP net loss |
|
$ |
(538 |
) |
|
$ |
(1,551 |
) |
|
$ |
(2,873 |
) |
|
$ |
(3,674 |
) |
Number of shares used in computing Non-GAAP loss per share (diluted) |
|
|
23,952,555 |
|
|
|
19,449,283 |
|
|
|
23,933,033 |
|
|
|
19,002,758 |
|
Non-GAAP loss per share (diluted) |
|
$ |
(0.02 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.12 |
) |
|
|
(0.19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(1,248 |
) |
|
$ |
(2,169 |
) |
|
$ |
(3,472 |
) |
|
$ |
(5,410 |
) |
Stock-based compensation |
|
|
24 |
|
|
|
36 |
|
|
|
89 |
|
|
|
100 |
|
Depreciation |
|
|
63 |
|
|
|
89 |
|
|
|
207 |
|
|
|
283 |
|
Amortization of intangibles |
|
|
686 |
|
|
|
582 |
|
|
|
2,038 |
|
|
|
1,636 |
|
Interest expense |
|
|
90 |
|
|
|
150 |
|
|
|
285 |
|
|
|
369 |
|
CARES Act PPP loan forgiveness |
|
|
— |
|
|
— |
|
|
|
(1,528 |
) |
|
|
— |
|
|
Provision for income taxes |
|
|
25 |
|
|
|
17 |
|
|
|
60 |
|
|
|
39 |
|
Non-GAAP Adjusted EBITDA |
|
$ |
(360 |
) |
|
$ |
(1,295 |
) |
|
$ |
(2,321 |
) |
|
$ |
(2,983 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115006532/en/
801-975-7200
investor_relations@clearone.com
http://investors.clearone.com
Source:
FAQ
What were ClearOne's Q3 2022 revenue figures for CLRO?
How did ClearOne's operating expenses change in Q3 2022?
What is the status of ClearOne's net loss for Q3 2022?
What factors impacted ClearOne's revenue performance in Q3 2022?